Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
"Group T-Bursa Yuksek Ihtisas Training and Research Hospital-postoperative pain" refers to a specific treatment arm in a clinical trial conducted at Bursa Yuksek Ihtisas Training and Research Hospital. This arm utilizes a combination of the local anesthetic bupivacaine and the opioid analgesic tramadol for the management of postoperative pain in patients undergoing laparoscopic cholecystectomy. The protocol involves an ultrasound-guided External Oblique and Rectus Abdominis plane (EXORA) block using 0.25% bupivacaine (administered with a specific 2-minute injection duration in Group T) to provide regional analgesia, supplemented by intravenous tramadol via patient-controlled analgesia (PCA). Bupivacaine acts by blocking voltage-gated sodium channels to inhibit nerve conduction, while tramadol provides systemic analgesia through mu-opioid receptor agonism and inhibition of serotonin and norepinephrine reuptake. The study specifically investigates how the duration of the fascial plane block injection influences the spread of the local anesthetic and the overall success of the block.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Group T-Bursa Yuksek Ihtisas Training and Research Hospital-postoperative pain.